Specialized Physical Therapy for Men, Women & Children | Licensed in South Carolina
Dupuytren’s disease changes the fibrous tissue beneath the skin of the palm and fingers. It often begins as a firm lump or a small area of puckered skin. Some people develop no further restriction, while others develop thickened bands that gradually tether a finger toward the palm. The resulting loss of straightening is called a contracture. A nodule, a cord, and a contracture are related findings, but they do not necessarily develop together or progress at the same rate.[1,2]
The palmar fascia lies beneath the skin and above the tendons that bend the fingers. Its attachments stabilize the palm’s skin during gripping. In Dupuytren’s disease, parts of this supporting tissue become thickened and shortened. Attachments to the skin produce dimples or pits, while bands extending toward a finger can restrict its movement. A prominent cord can resemble a tendon, but it is diseased fascia rather than a tendon that has tightened.[1]
The tissue changes involve collagen, the structural protein in connective tissue, and cells called myofibroblasts. These cells produce connective tissue and generate tension within it. Studies of human Dupuytren’s nodules show interactions among these cells, immune cells, and local chemical signals that sustain a fibrotic process. Fibrosis means excessive accumulation and remodeling of fibrous tissue. Because the restriction develops within this tissue rather than from a muscle remaining contracted, relaxing the hand or strengthening the muscles that straighten the fingers does not remove an established cord.[3]
A nodule contains biologically active tissue, whereas an established cord provides a substantial mechanical restraint. Reducing a nodule’s tenderness or size does not necessarily release a contracture. Conversely, dividing a cord can improve straightening without eliminating the tendency to form abnormal tissue. Treatments directed at early nodules and procedures directed at established contractures therefore address different aspects of the disease.[3]
A cord crossing the palm can prevent straightening at the metacarpophalangeal joint, or MCP joint, where the finger meets the hand. Disease extending farther into the finger can affect the proximal interphalangeal joint, or PIP joint, the middle finger joint. The ring and little fingers are affected most often, although other fingers and the thumb can be involved.[1]
PIP contractures are generally harder to correct completely than MCP contractures. With a longstanding bend, restriction is no longer necessarily confined to the cord. The tissues surrounding the joint can also shorten and stiffen, leaving residual restriction after the diseased fascia has been released. The joint involved, the severity of the bend, and its duration influence how much straightening is achievable. A procedure can successfully divide or remove a cord without restoring full joint motion.[1,4]
A person can retain useful gripping strength while struggling to release an object or spread the hand around it. Increasing grip strength does not lengthen the shortened fascia. Difficulty reaching into a pocket, putting on gloves, washing the face, or opening the hand around a large object reflects a loss of available opening rather than necessarily a loss of muscle force.[1,4]
Pain is also an unreliable measure of progression. Early nodules can hurt when pressed against a tool handle or steering wheel, but tenderness often settles. A finger can continue losing extension without becoming more painful. Changes in straightening and daily use are therefore more useful for monitoring the contracture than pain alone.[2]
Dupuytren’s disease has a substantial inherited component, but family history does not determine its course. Age, diabetes, smoking, and alcohol exposure have associations with the condition. These associations do not establish why an individual developed it, and many affected people have none of the commonly recognized risk factors. Avoiding all hand use is not an established way to prevent progression.[2,5]
Some nodules remain stable for years, while others enlarge or develop associated contracture. Earlier onset, disease in both hands, a family history, and related fibrous conditions elsewhere are associated with a greater tendency toward progression or recurrence. None reliably predicts what will happen to a particular finger. An unchanged lump provides evidence of stability during that interval, not a guarantee that it will never change.[5]
Observation is reasonable when the fingers straighten adequately and the hand remains useful. Resting the palm and fingers on a flat surface without forcing them provides a simple reference for extension. A new inability to place the hand flat, increasing bending at a middle finger joint, or interference with daily tasks warrants a hand specialist assessment. Consultation does not commit someone to a procedure, but it allows the restriction and available options to be reviewed before further motion is lost.[1,2]
Dupuytren’s usually causes a persistent restriction rather than a finger that intermittently catches and releases. Clicking or locking during movement suggests another problem, such as trigger finger, although both conditions can coexist. A new lump, substantial pain, or symptoms that do not fit the established pattern should be examined rather than assumed to represent ordinary progression.[1,2]
Home management can reduce pressure discomfort and preserve use of the movement that remains. It has not been established as a way to dissolve a cord or prevent future contracture. Studies of stretching, splints, massage, and other conservative treatments have reported some improvements, but most are small, use different methods, and have limited follow up. They do not establish a universal exercise program or reliable long term disease control.[6]
For an untreated hand, gentle active opening and closing is an option when it remains comfortable. Rest the forearm on a surface, slowly open the fingers within the available range, and then make a relaxed fist. The purpose is to use existing movement rather than force a contracted finger straight. This is an illustrative movement option, not a validated Dupuytren’s prevention protocol with a prescribed repetition count. Reduce or stop it if tenderness, swelling, or difficulty moving increases afterward.[6]
Pressure relief should target the activity that makes a nodule sore. A padded glove, a cushioned handle, or a different hand position can reduce direct contact during gardening, cycling, or tool use. For example, cushioning the part of a handle that presses against the lump may make gripping more comfortable without requiring a change to every other hand activity. These adaptations address contact discomfort; improvement does not show that the cord has lengthened or that progression has stopped.[5]
Tasks that require a flat palm may need a different approach when the finger cannot straighten fully. A handle or alternative hand position can sometimes preserve the activity without forcing the palm down. If adaptations become increasingly awkward or transfer strain elsewhere, a hand therapist can help select a workable alternative. Continuing loss of opening warrants reassessment rather than progressively greater stretching force.[1,4]
Forceful stretching can injure the finger or hand. Pulling hard on the fingertip, leaning body weight through a contracted finger, or attempting to break a cord is not an appropriate home treatment. A splint should not be purchased on the assumption that holding the finger straight will prevent progression. Splint selection needs an individual purpose, particularly when the skin is sensitive or the joint has a fixed bend.[1,4]
Temporary comfort after movement or massage does not establish structural change in the fascia. If a finger increasingly obstructs work, hygiene, or self care, home measures should not replace assessment of the contracture. After an injection or operation, use the treating team’s movement and protection instructions rather than an untreated hand routine.[4,6]
Procedures interrupt or remove the fascia that restrains the finger. Selection depends on the affected joint, cord location, skin condition, previous treatment, and the balance between recovery demands and durability. A less invasive treatment can be appropriate for someone who prioritizes a smaller procedure and accepts a greater likelihood of further treatment. More extensive tissue removal can provide a longer lasting correction but requires a different recovery and carries additional risks.[4,7]
Needle fasciotomy, also called needle aponeurotomy, divides a cord through small skin punctures. Interrupting the band reduces its tethering effect, allowing the finger to straighten farther. The diseased tissue remains in the hand. Suitability depends on the cord’s location and its relationship to nearby nerves, blood vessels, and tendons, not simply the visible degree of bending.[1,4]
Recovery is generally shorter than after open tissue removal, but contracture tends to recur earlier. Skin tears and injury to surrounding structures are possible. Existing joint stiffness can also limit correction even when the cord has been divided successfully. The expected result should therefore be discussed for the particular finger rather than inferred from another person’s experience.[4,7]
In the United States, collagenase clostridium histolyticum, marketed as Xiaflex, is approved for adults with Dupuytren’s contracture and a palpable cord. The enzyme breaks down collagen within the injected cord. A subsequent clinician performed finger extension procedure disrupts the weakened band. It is not simply an injection for pain and is not intended for every isolated palm nodule.[8]
Swelling, bruising, pain, and skin tears can occur. Less common but serious complications include tendon rupture and severe allergic reactions. Because tendons and ligaments also contain collagen, accurate placement and controlled aftercare are essential. Anticoagulants, bleeding disorders, and previous reactions require review before treatment. Do not stop prescribed blood thinners independently or attempt to rupture the cord yourself after injection.[8]
Limited fasciectomy removes selected diseased fascia through an incision. It allows the surgeon to identify and protect surrounding structures while removing the restrictive tissue. The wound still needs to heal, and postoperative swelling and scar formation can limit movement. Removing a cord does not immediately restore comfortable gripping or endurance for prolonged hand use.[1,4]
When skin is substantially involved, or in selected recurrent cases, dermofasciectomy removes affected skin as well as fascia. A skin graft covers the area, adding another healing and protection requirement. More extensive tissue removal does not eliminate the possibility of future disease.[2,4]
A 2025 individual patient data meta analysis found broadly comparable clinically meaningful contracture correction among limited fasciectomy, needle fasciotomy, and collagenase, but recurrence occurred earlier after needle treatment and collagenase.[7] In the DISC randomized trial of moderate contracture, patient reported hand health at one year favored limited fasciectomy over collagenase, while moderate or severe complications were more frequent after surgery. The choice therefore requires consideration of durability, recovery demands, and risk rather than an assumption that the smallest or most extensive procedure is always preferable.[9]
After treatment, the finger may have more available extension while the hand remains swollen, tender, and difficult to close. Rehabilitation needs to address opening and closing rather than pursue straightening at the expense of a useful fist. Exercises can include active finger movement, tendon gliding, and later resistance, with timing determined by the procedure, wound condition, and any additional surgical work.[4]
These activities train different abilities. Active extension practices using the muscles within the newly available range. Tendon gliding moves the bending tendons through their surrounding tissues. Resistance exercise rebuilds force production, while repeated task practice develops tolerance for activities such as carrying bags or handling tools. Improvement in one ability does not establish recovery of the others or removal of the tendency toward Dupuytren’s disease.[4]
Splinting after treatment is procedure specific. A randomized trial after fasciectomy or dermofasciectomy found no additional average benefit from routinely adding night splinting to hand therapy for every patient. Some patients still need an orthosis when extension is being lost or a particular restriction requires positioning. This finding does not justify independently discontinuing a prescribed splint and does not replace the separate aftercare instructions for collagenase treatment.[8,10]
Wound healing, skin tolerance, swelling, motion, and the ability to sustain a task all influence return to demanding use. A straighter finger or closed incision does not establish readiness for prolonged gardening, heavy lifting, or manual work. Progression should follow the treating team’s instructions and the demands of the intended activity rather than appearance alone.[1,4]
A finger that never fully straightens after treatment has residual contracture. A finger that initially gains extension and later bends again has recurrent restriction, which requires reassessment to determine its cause. Disease can also develop in a previously unaffected part of the hand. These outcomes are not interchangeable and should not automatically be attributed to inadequate exercise.[5,7]
Arrange review for increasing loss of extension, declining hand use, or a painful lump that has not been assessed. Rapid change, substantial new pain, or altered sensation should not be assumed to be ordinary Dupuytren’s progression. After a procedure, a newly pale or cold finger, worsening numbness, spreading redness, drainage, or sudden loss of the ability to bend a finger requires prompt assessment. Breathing difficulty or facial swelling after collagenase requires emergency care.[1,8]
American Academy of Orthopaedic Surgeons. Dupuytren’s disease. OrthoInfo. Accessed November 22, 2026.
British Society for Surgery of the Hand. Dupuytren’s disease. Patient information. Accessed November 22, 2026.
Nanchahal J, Chan JKK. Treatments for early-stage Dupuytren’s disease: an evidence-based approach. Journal of Hand Surgery (European Volume). 2023;48(3):191–198. doi:10.1177/17531934221131373.
Kemler MA, de Wijn RS, van Rijssen AL, van Kooij YE, Ottenhof MPM, van Heijl M, Steenbakkers RJHM, Geise JBJ. Dutch multidisciplinary guideline on Dupuytren disease. Journal of Hand Surgery Global Online. 2023;5(2):178–183. doi:10.1016/j.jhsg.2022.11.008.
Ruettermann M, Hermann RM, Khatib-Chahidi K, Werker PMN. Dupuytren’s disease: etiology and treatment. Deutsches Ärzteblatt International. 2021;118(46):781–788. doi:10.3238/arztebl.m2021.0325.
Fernando JJ, Fowler C, Graham T, Terry K, Grocott P, Sandford F. Pre-operative hand therapy management of Dupuytren’s disease: a systematic review. Hand Therapy. 2024;29(2):52–61. doi:10.1177/17589983241227162.
van den Berge BA, Habibi H, Dijkstra PU, et al. Outcomes of limited fasciectomy, needle fasciotomy and collagenase injection for Dupuytren’s disease: a systematic review and meta-analysis of individual patient data. Journal of Hand Surgery (European Volume). 2025;50(7):878–890. doi:10.1177/17531934251338349.
Endo USA, Inc. Xiaflex (collagenase clostridium histolyticum) for injection: prescribing information and Medication Guide. DailyMed. Accessed November 22, 2026.
Dias J, Tharmanathan P, Arundel C, et al. Collagenase injection versus limited fasciectomy for Dupuytren’s contracture. New England Journal of Medicine. 2024;391(16):1499–1510. doi:10.1056/NEJMoa2312631.
Jerosch-Herold C, Shepstone L, Chojnowski AJ, Larson D, Barrett E, Vaughan SP. Night-time splinting after fasciectomy or dermo-fasciectomy for Dupuytren’s contracture: a pragmatic, multi-centre, randomised controlled trial. BMC Musculoskeletal Disorders. 2011;12:136. doi:10.1186/1471-2474-12-136.